Lack of effect on cardiac repolarisation with teriflunomide compared with placebo: a thorough ECG study

被引：0
|
作者：
Menguy-Vacheron, F.
Msihid, J.
Poitiers, F.
Miller, B.
Turpault, S.
Voiriot, P.
Fauchoux, N.
机构：
[1] Sanofi Aventis, Chilly Mazarin, France
[2] Sanofi Aventis, Bridgewater, MA USA
[3] Sanofi Aventis, Malvern, PA USA
[4] Cardiabase, Nancy, France
[5] Biotrial, Rennes, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P458
引用
收藏
页码：S192 / S192
页数：1
相关论文
共 50 条
  • [41] Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study
    Sanjeev Khindri
    Ronald Sabo
    Stuart Harris
    Ralph Woessner
    Simon Jennings
    Anton F Drollmann
    BMC Pulmonary Medicine, 11
  • [42] Lack of effect of intravenous immunoglobulins on tics: A double-blind placebo-controlled study
    Hoekstra, PJ
    Minderaa, RB
    Kallenberg, CGM
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (04) : 537 - 542
  • [43] Clinical and Model-Based Evaluation of the Effect of Glasdegib on Cardiac Repolarization From a Randomized Thorough QT Study
    Masters, Joanna C.
    Shaik, Naveed
    da Costa, Laure Mendes
    Hee, Brian
    LaBadie, Robert R.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (03): : 272 - 282
  • [44] A Thorough QT/QTc Study of the Effect of Fasiglifam, a GPR40 Agonist, on Cardiac Repolarization in Healthy Adults
    Lee, Ronald D.
    Nudurupati, Sai
    Marcinak, John
    Viswanathan, Prabhakar
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (03): : 175 - 183
  • [45] The effect of the glucosylceramide synthase inhibitor lucerastat on cardiac repolarization: results from a thorough QT study in healthy subjects
    Markus S. Mueller
    Patricia N. Sidharta
    Christine Voors-Pette
    Borje Darpo
    Hongqi Xue
    Jasper Dingemanse
    Orphanet Journal of Rare Diseases, 15
  • [46] The effect of the glucosylceramide synthase inhibitor lucerastat on cardiac repolarization: results from a thorough QT study in healthy subjects
    Mueller, Markus S.
    Sidharta, Patricia N.
    Voors-Pette, Christine
    Darpo, Borje
    Xue, Hongqi
    Dingemanse, Jasper
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [47] Assessment of the cardiac safety of veliparib in a thorough QT/QTc study at therapeutic doses in patients with relapsed/refractory solid tumors: a randomized, placebo-controlled crossover study
    Munasinghe, Wijith
    Tolcher, Anthony
    Calvo, Emiliano
    Gordon, Michael
    Jalving, Mathilde
    de Vos-Geelen, Judith
    Medina, Diane M.
    Bergau, Dennis M.
    Nuthalapati, Silpa
    Hoffman, David M.
    Shepherd, Stacie L.
    Xiong, Hao
    CANCER RESEARCH, 2016, 76
  • [48] Use of Early Clinical Trial Data to Support Thorough QT Study Waiver for Upadacitinib and Utility of Food Effect to Demonstrate ECG Assay Sensitivity
    Mohamed, Mohamed-Eslam F.
    Zeng, Jiewei
    Jiang, Ping
    Hosmane, Balakrishna
    Othman, Ahmed A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (05) : 836 - 842
  • [49] FLUMAZENIL FOR MIDAZOLAM REVERSAL - DOSE EFFECT RELATIONSHIPS COMPARED WITH DOXAPRAM IN A PLACEBO-CONTROLLED STUDY
    SCHNEIDER, I
    CAMU, F
    CLAEYS, MA
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 1988, : 117 - 121
  • [50] THE EFFECT OF Y-PHENYL-PROPYLCARBAMATE COMPARED WITH MEPROBAMATE AND PLACEBO - AN EXPERIMENTAL PSYCHOLOGICAL-STUDY
    IDESTROM, CM
    PSYCHOPHARMACOLOGIA, 1962, 3 (01): : 15 - 22
12345